Copyright Reports & Markets. All rights reserved.

Global Mononucleosis Diagnostic Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Mononucleosis Diagnostic Market Overview

    • 1.1 Product Overview and Scope of Mononucleosis Diagnostic
    • 1.2 Classification of Mononucleosis Diagnostic by Types
      • 1.2.1 Global Mononucleosis Diagnostic Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Mononucleosis Diagnostic Revenue Market Share by Types in 2018
      • 1.2.3 Monospot Test
      • 1.2.4 Complete Blood Count Test
      • 1.2.5 Epstein Barr Virus (EBV) Antibody Test
    • 1.3 Global Mononucleosis Diagnostic Market by Application
      • 1.3.1 Global Mononucleosis Diagnostic Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospitals
      • 1.3.3 Laboratories
      • 1.3.4 Others
    • 1.4 Global Mononucleosis Diagnostic Market by Regions
      • 1.4.1 Global Mononucleosis Diagnostic Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Mononucleosis Diagnostic Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Mononucleosis Diagnostic Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mononucleosis Diagnostic Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Mononucleosis Diagnostic Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mononucleosis Diagnostic Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Mononucleosis Diagnostic (2014-2024)

    2 Company Profiles

    • 2.1 Abbott Laboratories
      • 2.1.1 Business Overview
      • 2.1.2 Mononucleosis Diagnostic Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Abbott Laboratories Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Quidel Corporation
      • 2.2.1 Business Overview
      • 2.2.2 Mononucleosis Diagnostic Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Quidel Corporation Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Bio-Rad Laboratories
      • 2.3.1 Business Overview
      • 2.3.2 Mononucleosis Diagnostic Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Bio-Rad Laboratories Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 ELITechGroup
      • 2.4.1 Business Overview
      • 2.4.2 Mononucleosis Diagnostic Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 ELITechGroup Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Meridian Bioscience
      • 2.5.1 Business Overview
      • 2.5.2 Mononucleosis Diagnostic Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Meridian Bioscience Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Beckman Coulter
      • 2.6.1 Business Overview
      • 2.6.2 Mononucleosis Diagnostic Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Beckman Coulter Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Thermo Fischer Scientific
      • 2.7.1 Business Overview
      • 2.7.2 Mononucleosis Diagnostic Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Thermo Fischer Scientific Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Immunostics
      • 2.8.1 Business Overview
      • 2.8.2 Mononucleosis Diagnostic Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Immunostics Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Cardinal Health
      • 2.9.1 Business Overview
      • 2.9.2 Mononucleosis Diagnostic Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Cardinal Health Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Sekisui Diagnostics
      • 2.10.1 Business Overview
      • 2.10.2 Mononucleosis Diagnostic Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Sekisui Diagnostics Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Siemens
      • 2.11.1 Business Overview
      • 2.11.2 Mononucleosis Diagnostic Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Siemens Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Biomerieux
      • 2.12.1 Business Overview
      • 2.12.2 Mononucleosis Diagnostic Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Biomerieux Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Mononucleosis Diagnostic Market Competition, by Players

    • 3.1 Global Mononucleosis Diagnostic Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Mononucleosis Diagnostic Players Market Share
      • 3.2.2 Top 10 Mononucleosis Diagnostic Players Market Share
    • 3.3 Market Competition Trend

    4 Global Mononucleosis Diagnostic Market Size by Regions

    • 4.1 Global Mononucleosis Diagnostic Revenue and Market Share by Regions
    • 4.2 North America Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 4.5 South America Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)

    5 North America Mononucleosis Diagnostic Revenue by Countries

    • 5.1 North America Mononucleosis Diagnostic Revenue by Countries (2014-2019)
    • 5.2 USA Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)

    6 Europe Mononucleosis Diagnostic Revenue by Countries

    • 6.1 Europe Mononucleosis Diagnostic Revenue by Countries (2014-2019)
    • 6.2 Germany Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 6.3 UK Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 6.4 France Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Mononucleosis Diagnostic Revenue by Countries

    • 7.1 Asia-Pacific Mononucleosis Diagnostic Revenue by Countries (2014-2019)
    • 7.2 China Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 7.5 India Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)

    8 South America Mononucleosis Diagnostic Revenue by Countries

    • 8.1 South America Mononucleosis Diagnostic Revenue by Countries (2014-2019)
    • 8.2 Brazil Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Mononucleosis Diagnostic by Countries

    • 9.1 Middle East and Africa Mononucleosis Diagnostic Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Mononucleosis Diagnostic Revenue and Growth Rate (2014-2019)

    10 Global Mononucleosis Diagnostic Market Segment by Type

    • 10.1 Global Mononucleosis Diagnostic Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Mononucleosis Diagnostic Market Forecast by Type (2019-2024)
    • 10.3 Monospot Test Revenue Growth Rate (2014-2024)
    • 10.4 Complete Blood Count Test Revenue Growth Rate (2014-2024)
    • 10.5 Epstein Barr Virus (EBV) Antibody Test Revenue Growth Rate (2014-2024)

    11 Global Mononucleosis Diagnostic Market Segment by Application

    • 11.1 Global Mononucleosis Diagnostic Revenue Market Share by Application (2014-2019)
    • 11.2 Mononucleosis Diagnostic Market Forecast by Application (2019-2024)
    • 11.3 Hospitals Revenue Growth (2014-2019)
    • 11.4 Laboratories Revenue Growth (2014-2019)
    • 11.5 Others Revenue Growth (2014-2019)

    12 Global Mononucleosis Diagnostic Market Size Forecast (2019-2024)

    • 12.1 Global Mononucleosis Diagnostic Market Size Forecast (2019-2024)
    • 12.2 Global Mononucleosis Diagnostic Market Forecast by Regions (2019-2024)
    • 12.3 North America Mononucleosis Diagnostic Revenue Market Forecast (2019-2024)
    • 12.4 Europe Mononucleosis Diagnostic Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Mononucleosis Diagnostic Revenue Market Forecast (2019-2024)
    • 12.6 South America Mononucleosis Diagnostic Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Mononucleosis Diagnostic Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Description

      Scope of the Report:
      The global Mononucleosis Diagnostic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Mononucleosis Diagnostic.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Mononucleosis Diagnostic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Mononucleosis Diagnostic market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Abbott Laboratories
      Quidel Corporation
      Bio-Rad Laboratories
      ELITechGroup
      Meridian Bioscience
      Beckman Coulter
      Thermo Fischer Scientific
      Immunostics
      Cardinal Health
      Sekisui Diagnostics
      Siemens
      Biomerieux

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Monospot Test
      Complete Blood Count Test
      Epstein Barr Virus (EBV) Antibody Test

      Market Segment by Applications, can be divided into
      Hospitals
      Laboratories
      Others
      Buy now